A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease. | Transplantation;84(11): 1534-9, 2007 Dec 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A quantitative assay for Epstein-Barr Virus-specific immunity shows interferon-gamma producing CD8+ T cells increase during immunosuppression reduction to treat posttransplant lymphoproliferative disease.

Guppy, Amy E; Rawlings, Eira; Madrigal, J Alejandro; Amlot, Peter L; Barber, Linda D.

Affiliation

Guppy AE; Department of Immunology, Royal Free & University College Medical School, University College London, London, United Kingdom.

Transplantation ; 84(11): 1534-9, 2007 Dec 15.

Article in En | MEDLINE | ID: mdl-18091531

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Interferon-gamma / Herpesvirus 4, Human / CD8-Positive T-Lymphocytes / Immunosorbents / Lymphoproliferative Disorders Limits: Humans Language: En Journal: Transplantation Year: 2007 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Interferon-gamma / Herpesvirus 4, Human / CD8-Positive T-Lymphocytes / Immunosorbents / Lymphoproliferative Disorders Limits: Humans Language: En Journal: Transplantation Year: 2007 Document type: Article Affiliation country: